IndexIQ Advisors’s Idexx Laboratories IDXX Stock Holding History

IndexIQ Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$4.11M	Buy	7,517 +136	+2%	+$71.5K	0.15%	139
2021 Q4	$4.86M	Buy	7,381 +95	+1%	+$59.6K	0.16%	101
2021 Q3	$4.53M	Sell	7,286 -21	-0.3%	-$14.1K	0.15%	110
2021 Q2	$4.62M	Sell	7,307 -237	-3%	-$131K	0.16%	103
2021 Q1	$3.69M	Buy	7,544 +6,365	+540%	+$3.19M	0.13%	120
2020 Q4	$589K	Buy	+1,179	New	+$528K	0.02%	318
2020 Q1	–	Sell	-18,678	Closed	-$4.88M	–	1094
2019 Q4	$4.88M	Buy	18,678 +4,035	+28%	+$1.06M	0.17%	109
2019 Q3	$3.98M	Sell	14,643 -5,006	-25%	-$1.39M	0.14%	90
2019 Q2	$5.41M	Sell	19,649 -514	-3%	-$127K	0.17%	77
2019 Q1	$4.51M	Buy	+20,163	New	+$4.16M	0.13%	92

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

IndexIQ Advisors's IDXX Position: Q1 2022 in Review

IndexIQ Advisors increased its Idexx Laboratories (IDXX) stake by 1.8% in Q1 2022, buying an estimated $71.5K and bringing the position to 7,517 shares worth $4.11M. The position accounts for 0.15% of the portfolio, ranked #139.

IndexIQ Advisors first reported a position in IDXX in Q1 2019 and has held it in 10 quarters since. The position peaked at $5.41M in Q2 2019. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

IndexIQ Advisors held 7,517 shares of Idexx Laboratories worth $4.11M as of Q1 2022.
IndexIQ Advisors bought 136 Idexx Laboratories shares in Q1 2022, an estimated $71.5K.
Idexx Laboratories made up 0.15% of IndexIQ Advisors's portfolio in Q1 2022, its #139 holding.
IndexIQ Advisors first reported a position in Idexx Laboratories in Q1 2019 and has held it in 10 quarters since.
IndexIQ Advisors's Idexx Laboratories position peaked at $5.41M in Q2 2019.
1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.